This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Profectus Biosciences, Inc., The University of Texas System, Wyeth. Active years: 2009-2018.
Company Filing History:
1 out of 2 
1 out of 5,633 
1 out of 1,309 
Years Active: 2009-2018
Title: The Innovative Contributions of Theresa E. Latham
Introduction
Theresa E. Latham is a prominent inventor based in Mamaroneck, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of viral vectors and influenza virus-like particles. With a total of 3 patents, her work has advanced the understanding and application of recombinant technologies.
Latest Patents
Latham's latest patents include groundbreaking innovations. One of her patents focuses on "Recombinant isfahan viral vectors," which are directed to recombinant encoding a heterologous polynucleotide and methods of using the same. Another notable patent is for the "Assembly of wild-type and chimeric influenza virus-like particles (VLPs)." This patent describes influenza VLPs comprising the structural proteins HA, NA, M1, and M2. It also details the generation of VLPs containing M1 alone, as well as VLPs with M1 and any combination of HA, NA, and M2. Furthermore, her work includes VLPs with HA from one influenza subtype and NA from a different subtype, as well as chimeric VLPs that incorporate heterologous moieties not produced by influenza virus.
Career Highlights
Throughout her career, Latham has worked with notable organizations, including Wyeth Holdings Corporation and The University of Texas System. Her experience in these institutions has allowed her to refine her expertise and contribute to significant advancements in her field.
Collaborations
Latham has collaborated with esteemed colleagues such as Jose M. Galarza and Demetrius Matassov. These partnerships have fostered innovation and have been instrumental in her research endeavors.
Conclusion
Theresa E. Latham's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to influence the development of viral technologies and their applications in medicine.